Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Advantages and limitations of microarray technology in human cancer

Abstract

Cancer is a highly variable disease with multiple heterogeneous genetic and epigenetic changes. Functional studies are essential to understanding the complexity and polymorphisms of cancer. The final deciphering of the complete human genome, together with the improvement of high throughput technologies, is causing a fundamental transformation in cancer research. Microarray is a new powerful tool for studying the molecular basis of interactions on a scale that is impossible using conventional analysis. This technique makes it possible to examine the expression of thousands of genes simultaneously. This technology promises to lead to improvements in developing rational approaches to therapy as well as to improvements in cancer diagnosis and prognosis, assuring its entry into clinical practice in specialist centers and hospitals within the next few years. Predicting who will develop cancer and how this disease will behave and respond to therapy after diagnosis will be one of the potential benefits of this technology within the next decade. In this review, we highlight some of the recent developments and results in microarray technology in cancer research, discuss potentially problematic areas associated with it, describe the eventual use of microarray technology for clinical applications and comment on future trends and issues.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, Szabo M, Cantor A, Coppola D and Yeatman TJ . (2002). J. Natl. Cancer Inst., 94, 513–521.

  • Ahr A, Karn T, Solbach C, Seiter T, Strebhardt K, Holtrich U and Kaufmann M . (2002). Lancet, 359, 131–132.

  • Al Moustafa AE, Alaoui-Jamali MA, Batist G, Hernandez-Perez M, Serruya C, Alpert L, Black MJ, Sladek R and Foulkes WD . (2002). Oncogene, 21, 2634–2640.

  • Alevizos I, Mahadevappa M, Zhang X, Ohyama H, Kohno Y, Posner M, Gallagher GT, Varvares M, Cohen D, Kim D, Kent R, Donoff RB, Todd R, Yung CM, Warrington JA and Wong DT . (2001). Oncogene, 20, 6196–6204.

  • Alizadeh A, Eisen M, Davis RE, Ma C, Sabet H, Tran T, Powell JI, Yang L, Marti GE, Moore DT, Hudson Jr JR, Chan WC, Greiner T, Weisenburger D, Armitage JO, Lossos I, Levy R, Botstein D, Brown PO and Staudt LM . (1999). Cold Spring Harb. Symp. Quant. Biol., 64, 71–78.

  • Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson Jr J, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Staudt LM et al. (2000). Nature, 403, 503–511.

  • Alizadeh AA, Ross DT, Perou CM and van de Rijn M . (2001). J. Pathol., 195, 41–52.

  • Backert S, Gelos M, Kobalz U, Hanski ML, Bohm C, Mann B, Lovin N, Gratchev A, Mansmann U, Moyer MP, Riecken EO and Hanski C . (1999). Int. J. Cancer, 82, 868–874.

  • Barlund M, Forozan F, Kononen J, Bubendorf L, Chen Y, Bittner ML, Torhorst J, Haas P, Bucher C, Sauter G, Kallioniemi OP and Kallioniemi A . (2000a). J. Natl. Cancer. Inst., 92, 1252–1259.

  • Barlund M, Monni O, Kononen J, Cornelison R, Torhorst J, Sauter G, Kallioniemi O-P and Kallioniemi A . (2000b). Cancer Res., 60, 5340–5344.

  • Battifora H . (1986). Lab. Invest., 55, 244–248.

  • Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, Lizyness ML, Kuick R, Hayasaka S, Taylor JM, Iannettoni MD, Orringer MB and Hanash S . (2002). Nat. Med., 8, 816–824.

  • Belbin TJ, Singh B, Barber I, Socci N, Wenig B, Smith R, Prystowsky MB and Childs G . (2002). Cancer Res., 62, 1184–1190.

  • Bertucci F, Bernard K, Loriod B, Chang YC, Granjeaud S, Birnbaum D, Nguyen C, Peck K and Jordan BR . (1999). Hum. Mol. Genet., 8, 1715–1722.

  • Bertucci F, Nasser V, Granjeaud S, Eisinger F, Adelaide J, Tagett R, Loriod B, Giaconia A, Benziane A, Devilard E, Jacquemier J, Viens P, Nguyen C, Birnbaum D and Houlgatte R . (2002). Hum. Mol. Genet., 11, 863–872.

  • Best CJ and Emmert-Buck MR . (2001). Expert Rev. Mol. Diagn., 1, 53–60.

  • Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, Loda M, Weber G, Mark EJ, Lander ES, Wong W, Johnson BE, Golub TR, Sugarbaker DJ and Meyerson M . (2001). Proc. Natl. Acad. Sci. USA, 98, 13790–13795.

  • Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, Radmacher M, Simon R, Yakhini Z, Ben-Dor A, Sampas N, Dougherty E, Wang E, Marincola F, Gooden C, Lueders J, Glatfelter A, Pollock P, Carpten J, Gillanders E, Leja D, Dietrich K, Beaudry C, Berens M, Alberts D and Sondak V . (2000). Nature, 406, 536–540.

  • Bowtell DD . (1999). Nat. Genet., 21, 25–32.

  • Brail LH, Jang A, Billia F, Iscove NN, Klamut HJ and Hill RP . (1999). Mutat. Res., 406, 45–54.

  • Brown PO and Botstein D . (1999). Nat. Genet., 21, 33–37.

  • Bubendorf L, Kolmer M, Kononen J, Koivisto P, Mousses S, Chen Y, Mahlamaki E, Schraml P, Moch H, Willi N, Elkahloun AG, Pretlow TG, Gasser TC, Mihatsch MJ, Sauter G and Kallioniemi OP . (1999a). J. Natl. Cancer Inst., 91, 1758–1764.

  • Bubendorf L, Kononen J, Koivisto P, Schraml P, Moch H, Gasser TC, Willi N, Mihatsch MJ, Sauter G and Kallioniemi OP . (1999b). Cancer Res., 59, 803–806.

  • Bull JH, Ellison G, Patel A, Muir G, Walker M, Underwood M, Khan F and Paskins L . (2001). Br. J. Cancer, 84, 1512–1519.

  • Caldas C and Aparicio SA . (2002). Nature, 415, 484–485.

  • Celis JE, Kruhoffer M, Gromova I, Frederiksen C, Ostergaard M, Thykjaer T, Gromov P, Yu J, Palsdottir H, Magnusson N and Orntoft TF . (2000). FEBS Lett., 480, 2–16.

  • Chang DD, Park NH, Denny CT, Nelson SF and Pe M . (1998). Oncogene, 16, 1921–1930.

  • Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J, Lai KM, Ji J, Dudoit S, Ng IO, Van De Rijn M, Botstein D and Brown PO . (2002). Mol. Biol. Cell, 13, 1929–1939.

  • Cheng Q, Lau WM, Tay SK, Chew SH, Ho TH and Hui KM . (2002). Int. J. Cancer, 98, 419–426.

  • Cheung VG, Morley M, Aguilar F, Massimi A, Kucherlapati R and Childs G . (1999). Nat. Genet., 21, 15–19.

  • Collins FS . (1999). Nat. Genet., 21, 2.

  • Devilard E, Bertucci F, Trempat P, Bouabdallah R, Loriod B, Giaconia A, Brousset P, Granjeaud S, Nguyen C, Birnbaum D, Birg F, Houlgatte R and Xerri L . (2002). Oncogene, 21, 3095–3102.

  • Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA and Chinnaiyan AM . (2001). Nature, 412, 822–826.

  • Duggan DJ, Bittner M, Chen Y, Meltzer P and Trent JM . (1999). Nat. Genet., 21, 10–14.

  • Fejzo MS and Slamon DJ . (2001). Am. J. Pathol., 159, 1645–1650.

  • Frierson Jr HF, El-Naggar AK, Welsh JB, Sapinoso LM, Su AI, Cheng J, Saku T, Moskaluk CA and Hampton GM . (2002). Am. J. Pathol., 161, 1315–1323.

  • Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, Pacyna-Gengelbach M, van de Rijn M, Rosen GD, Perou CM, Whyte RI, Altman RB, Brown PO, Botstein D and Petersen I . (2001). Proc. Natl. Acad. Sci. USA, 98, 13784–13789.

  • Gariboldi M, Peissel B, Fabbri A, Saran A, Zaffaroni D, Falvella FS, Spinola M, Tanuma J, Pazzaglia S, Mancuso MT, Maurichi A, Bartoli C, Cataltepe S, Silverman GA, Pilotti S, Hayashizaki Y, Okazaki Y and Dragani TA . (2003). Cancer Res., 63, 1871–1875.

  • Giordano TJ, Shedden KA, Schwartz DR, Kuick R, Taylor JM, Lee N, Misek DE, Greenson JK, Kardia SL, Beer DG, Rennert G, Cho KR, Gruber SB, Fearon ER and Hanash S . (2001). Am. J. Pathol., 159, 1231–1238.

  • Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD and Lander ES . (1999). Science, 286, 531–537.

  • Gordon GJ, Jensen RV, Hsiao LL, Gullans SR, Blumenstock JE, Ramaswamy S, Richards WG, Sugarbaker DJ and Bueno R . (2002). Cancer Res., 62, 4963–4967.

  • Granjeaud S, Bertucci F and Jordan BR . (1999). Bioessays, 21, 781–790.

  • Graves DJ . (1999). Trends Biotechnol., 17, 127–134.

  • Han H, Bearss DJ, Browne LW, Calaluce R, Nagle RB and Von Hoff DD . (2002). Cancer Res., 62, 2890–2896.

  • Hanash S . (2003). Nat. Biotechnol., 21, 37–38.

  • Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R, Meltzer P, Gusterson B, Esteller M, Kallioniemi OP, Wilfond B, Borg A and Trent J . (2001). N. Engl. J. Med., 344, 539–548.

  • Hedenfalk IA, Ringner M, Trent JM and Borg A . (2002). Adv. Cancer Res., 84, 1–34.

  • Hegde P, Qi R, Abernathy K, Gay C, Dharap S, Gaspard R, Hughes JE, Snesrud E, Lee N and Quackenbush J . (2000). Biotechniques, 29, 548–550 552–554, 556 passim.

  • Hippo Y, Taniguchi H, Tsutsumi S, Machida N, Chong JM, Fukayama M, Kodama T and Aburatani H . (2002). Cancer Res., 62, 233–240.

  • Hofmann WK, de Vos S, Elashoff D, Gschaidmeier H, Hoelzer D, Koeffler HP and Ottmann OG . (2002). Lancet, 359, 481–486.

  • Hong TM, Yang PC, Peck K, Chen JJ, Yang SC, Chen YC and Wu CW . (2000). Am. J. Respir. Cell Mol. Biol., 23, 355–363.

  • Hoos A, Urist MJ, Stojadinovic A, Mastorides S, Dudas ME, Leung DH, Kuo D, Brennan MF, Lewis JJ and Cordon-Cardo C . (2001). Am. J. Pathol., 158, 1245–1251.

  • Hubert RS, Vivanco I, Chen E, Rastegar S, Leong K, Mitchell SC, Madraswala R, Zhou Y, Kuo J, Raitano AB, Jakobovits A, Saffran DC and Afar DE . (1999). Proc. Natl. Acad. Sci. USA, 96, 14523–14528.

  • Ismail RS, Baldwin RL, Fang J, Browning D, Karlan BY, Gasson JC and Chang DD . (2000). Cancer Res., 60, 6744–6749.

  • Jiang Z, Woda BA, Rock KL, Xu Y, Savas L, Khan A, Pihan G, Cai F, Babcook JS, Rathanaswami P, Reed SG, Xu J and Fanger GR . (2001). Am. J. Surg. Pathol., 25, 1397–1404.

  • Kallioniemi OP, Wagner U, Kononen J and Sauter G . (2001). Hum. Mol. Genet., 10, 657–662.

  • Khan J, Saal LH, Bittner ML, Chen Y, Trent JM and Meltzer PS . (1999). Electrophoresis, 20, 223–229.

  • Khan J, Simon R, Bittner M, Chen Y, Leighton SB, Pohida T, Smith PD, Jiang Y, Gooden GC, Trent JM. and Meltzer PS . (1998). Cancer Res., 58, 5009–5013.

  • Khan J, Wei JS, Ringner M, Saal LH, Ladanyi M, Westermann F, Berthold F, Schwab M, Antonescu CR, Peterson C and Meltzer PS . (2001). Nat. Med., 7, 673–679.

  • Kim JH, Skates SJ, Uede T, Wong Kk, KK, Schorge JO, Feltmate CM, Berkowitz RS, Cramer DW and Mok SC . (2002). JAMA, 287, 1671–1679.

  • Knezevic V, Leethanakul C, Bichsel VE, Worth JM, Prabhu VV, Gutkind JS, Liotta LA, Munson PJ, Petricoin III EF and Krizman DB . (2001). Proteomics, 1, 1271–1278.

  • Kodadek T . (2001). Chem. Biol., 8, 105–115.

  • Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G and Kallioniemi OP . (1998). Nat. Med., 4, 844–847.

  • Kudoh K, Ramanna M, Ravatn R, Elkahloun AG, Bittner ML, Meltzer PS, Trent JM, Dalton WS and Chin KV . (2000). Cancer Res., 60, 4161–4166.

  • Lander ES . (1999). Nat. Genet., 21, 3–4.

  • Leethanakul C, Knezevic V, Patel V, Amornphimoltham P, Gillespie J, Shillitoe EJ, Emko P, Park MH, Emmert-Buck MR, Strausberg RL, Krizman DB and Gutkind JS . (2003). Oral Oncol., 39, 248–258.

  • Lipshutz RJ, Fodor SP, Gingeras TR and Lockhart DJ . (1999). Nat. Genet., 21, 20–24.

  • Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H and Brown EL . (1996). Nat. Biotechnol., 14, 1675–1680.

  • Lu J, Liu Z, Xiong M, Wang Q, Wang X, Yang G, Zhao L, Qiu Z, Zhou C and Wu M . (2001). Int. J. Cancer, 91, 288–294.

  • Luo J, Duggan DJ, Chen Y, Sauvageot J, Ewing CM, Bittner ML, Trent JM and Isaacs WB . (2001). Cancer Res., 61, 4683–4688.

  • Luo J, Dunn T, Ewing C, Sauvageot J, Chen Y, Trent J and Isaacs W . (2002a). Prostate, 51, 189–200.

  • Luo JH, Yu YP, Cieply K, Lin F, Deflavia P, Dhir R, Finkelstein S, Michalopoulos G and Becich M . (2002b). Mol. Carcinogen, 33, 25–35.

  • Luo L, Salunga RC, Guo H, Bittner A, Joy KC, Galindo JE, Xiao H, Rogers KE, Wan JS, Jackson MR and Erlander MG . (1999). Nat. Med., 5, 117–122.

  • Martin KJ, Graner E, Li Y, Price LM, Kritzman BM, Fournier MV, Rhei E and Pardee AB . (2001). Proc. Natl. Acad. Sci. USA, 98, 2646–2651.

  • Martoglio AM, Tom BD, Starkey M, Corps AN, Charnock-Jones DS and Smith SK . (2000). Mol. Med., 6, 750–765.

  • Matei D, Graeber TG, Baldwin RL, Karlan BY, Rao J and Chang DD . (2002). Oncogene, 21, 6289–6298.

  • Meldrum D . (2000). Genome Res., 10, 1288–1303.

  • Mintz PJ, Kim J, Do KA, Wang X, Zinner RG, Cristofanilli M, Arap MA, Hong WK, Troncoso P, Logothetis CJ, Pasqualini R and Arap W . (2003). Nat. Biotechnol., 21, 57–63.

  • Moch H, Schraml P, Bubendorf L, Mirlacher M, Kononen J, Gasser T, Mihatsch MJ, Kallioniemi OP and Sauter G . (1999). Am. J. Pathol., 154, 981–986.

  • Mok SC, Chao J, Skates S, Wong K, Yiu GK, Muto MG, Berkowitz RS and Cramer DW . (2001). J. Natl. Cancer Inst., 93, 1458–1464.

  • Niemeyer CM and Blohm D . (1999). Angew Chem. Int. Ed. Engl., 38, 2865–2869.

  • Nocito A, Bubendorf L, Maria Tinner E, Suess K, Wagner U, Forster T, Kononen J, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Anabitarte M, Hering F, Hardmeier T, Schoenenberger AJ, Flury R, Jager P, Luc Fehr J, Schraml P, Moch H, Mihatsch MJ, Gasser T and Sauter G . (2001). J. Pathol., 194, 349–357.

  • Ono K, Tanaka T, Tsunoda T, Kitahara O, Kihara C, Okamoto A, Ochiai K, Takagi T and Nakamura Y . (2000). Cancer Res., 60, 5007–5011.

  • Paweletz CP, Charboneau L, Bichsel VE, Simone NL, Chen T, Gillespie JW, Emmert-Buck MR, Roth MJ, Petricoin IE and Liotta LA . (2001). Oncogene, 20, 1981–1989.

  • Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO and Botstein D . (2000). Nature, 406, 747–752.

  • Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M, Ladd C, Reich M, Latulippe E, Mesirov JP, Poggio T, Gerald W, Loda M, Lander ES and Golub TR . (2001). Proc. Natl. Acad. Sci. USA, 98, 15149–15154.

  • Richter J, Wagner U, Kononen J, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Wilber K, Anabitarte M, Hering F, Hardmeier T, Schonenberger A, Flury R, Jager P, Fehr JL, Schraml P, Moch H, Mihatsch MJ, Gasser T, Kallioniemi OP and Sauter G . (2000). Am. J. Pathol., 157, 787–794.

  • Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, Yang L, Pickeral OK, Rassenti LZ, Powell J, Botstein D, Byrd JC, Grever MR, Cheson BD, Chiorazzi N, Wilson WH, Kipps TJ, Brown PO and Staudt LM . (2001). J. Exp. Med., 194, 1639–1647.

  • Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Montserrat E, Lopez-Guillermo A, Grogan TM, Miller TP, LeBlanc M, Ott G, Kvaloy S, Delabie J, Holte H, Krajci P, Stokke T and Staudt LM . (2002). N. Engl. J. Med, 346, 1937–1947.

  • Russo G, Claudio PP, Fu Y, Stiegler P, Yu ZL and Macaluso M and Giordano A . (2003). Oncogene (in press).

  • Sallinen SL, Sallinen PK, Haapasalo HK, Helin HJ, Helen PT, Schraml P, Kallioniemi OP and Kononen J . (2000). Cancer Res., 60, 6617–6622.

  • Sawiris GP, Sherman-Baust CA, Becker KG, Cheadle C, Teichberg D and Morin PJ . (2002). Cancer Res., 62, 2923–2928.

  • Schena M, Shalon D, Davis RW and Brown PO . (1995). Science, 270, 467–470.

  • Schena M, Shalon D, Heller R, Chai A, Brown PO and Davis RW . (1996). Proc. Natl. Acad. Sci. USA, 93, 10614–10619.

  • Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT, Scudiero DA, Eisen MB, Sausville EA, Pommier Y, Botstein D, Brown PO and Weinstein JN . (2000). Nat. Genet., 24, 236–244.

  • Schraml P, Kononen J, Bubendorf L, Moch H, Bissig H, Nocito A, Mihatsch MJ, Kallioniemi OP and Sauter G . (1999). Clin. Cancer Res., 5, 1966–1975.

  • Senior K . (1999). Mol. Med. Today, 5, 326–327.

  • Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, Gaasenbeek M, Angelo M, Reich M, Pinkus GS, Ray TS, Koval MA, Last KW, Norton A, Lister TA, Mesirov J, Neuberg DS, Lander ES, Aster JC and Golub TR . (2002). Nat. Med., 8, 68–74.

  • Shridhar V, Lee J, Pandita A, Iturria S, Avula R, Staub J, Morrissey M, Calhoun E, Sen A, Kalli K, Keeney G, Roche P, Cliby W, Lu K, Schmandt R, Mills GB, Bast Jr RC, James CD, Couch FJ, Hartmann LC, Lillie J and Smith DI . (2001). Cancer Res., 61, 5895–5904.

  • Simon R, Nocito A, Hubscher T, Bucher C, Torhorst J, Schraml P, Bubendorf L, Mihatsch MM, Moch H, Wilber K, Schotzau A, Kononen J and Sauter G . (2001). J. Natl. Cancer Inst., 93, 1141–1146.

  • Simon R, Struckmann K, Schraml P, Wagner U, Forster T, Moch H, Fijan A, Bruderer J, Wilber K, Mihatsch MJ, Gasser T and Sauter G . (2002). Oncogene, 21, 2476–2483.

  • Simone NL, Bonner RF, Gillespie JW, Emmert-Buck MR and Liotta LA . (1998). Trends Genet., 14, 272–276.

  • Singh D, Febbo PG, Ross K, Jackson DG, Manola J ., Tamayo P, Renshaw AA, D'Amico AV, Richie JP, Lander ES, Loda M, Kantoff PW, Golub TR and Sellers WR . (2002). Cancer Cell, 1, 203–209.

  • Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P and Borresen-Dale AL . (2001). Proc. Natl. Acad. Sci. USA, 98, 10869–10874.

  • Sotiriou C, Powles TJ, Dowsett M, Jazaeri AA, Feldman AL, Assersohn L, Gadisetti C, Libutti SK and Liu ET . (2002). Breast Cancer Res., 4, R3.

  • Southern E, Mir K and Shchepinov M . (1999). Nat. Genet., 21, 5–9.

  • Staunton JE, Slonim DK, Coller HA, Tamayo P, Angelo MJ, Park J, Scherf U, Lee JK, Reinhold WO, Weinstein JN, Mesirov JP, Lander ES and Golub TR . (2001). Proc. Natl. Acad. Sci. USA, 98, 10787–10792.

  • Stratowa C, Loffler G, Lichter P, Stilgenbauer S, Haberl P, Schweifer N, Dohner H and Wilgenbus KK . (2001). Int. J. Cancer, 91, 474–480.

  • Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, Orth AP, Vega RG, Sapinoso LM, Moqrich A, Patapoutian A, Hampton GM, Schultz PG and Hogenesch JB . (2002). Proc. Natl. Acad. Sci. USA, 99, 4465–4470.

  • Su AI, Welsh JB, Sapinoso LM, Kern SG, Dimitrov P, Lapp H, Schultz PG, Powell SM, Moskaluk CA, Frierson Jr HF and Hampton GM . (2001). Cancer Res., 61, 7388–7393.

  • Takahashi M, Rhodes DR, Furge KA, Kanayama H, Kagawa S, Haab BB and Teh BT . (2001). Proc. Natl. Acad. Sci. USA, 98, 9754–9759.

  • Tonin PN, Hudson TJ, Rodier F, Bossolasco M, Lee PD, Novak J, Manderson EN, Provencher D and Mes-Masson AM . (2001). Oncogene, 20, 6617–6626.

  • Torhorst J, Bucher C, Kononen J, Haas P, Zuber M, Kochli OR, Mross F, Dieterich H, Moch H, Mihatsch M, Kallioniemi OP and Sauter G . (2001). Am. J. Pathol., 159, 2249–2256.

  • van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R and Friend SH . (2002). Nature, 415, 530–536.

  • Velculescu VE, Zhang L, Vogelstein B and Kinzler KW . (1995). Science, 270, 484–487.

  • Villaret DB, Wang T, Dillon D, Xu J, Sivam D, Cheever MA and Reed SG . (2000). Laryngoscope, 110, 374–381.

  • Virolle T, Krones-Herzig A, Baron V, De Gregorio G, Adamson ED and Mercola D . (2003). J. Biol. Chem., 278, 11802–11810.

  • von Eggeling F, Davies H, Lomas L, Fiedler W, Junker K, Claussen U and Ernst G . (2000). Biotechniques, 29, 1066–1070.

  • Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, Frierson Jr HF and Hampton GM . (2001a). Cancer Res., 61, 5974–5978.

  • Welsh JB, Zarrinkar PP, Sapinoso LM, Kern SG, Behling CA, Monk BJ, Lockhart DJ, Burger RA and Hampton GM . (2001b). Proc. Natl. Acad. Sci. USA, 98, 1176–1181.

  • West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, Zuzan H, Olson Jr JA, Marks JR and Nevins JR . (2001). Proc. Natl. Acad. Sci. USA, 98, 11462–11467.

  • Xu J, Kalos M, Stolk JA, Zasloff EJ, Zhang X, Houghton RL, Filho AM, Nolasco M, Badaro R and Reed SG . (2001). Cancer Res., 61, 1563–1568.

  • Zhou M, Chinnaiyan AM, Kleer CG, Lucas PC and Rubin MA . (2002). Am. J. Surg. Pathol., 26, 926–931.

Download references

Acknowledgements

We are grateful to Marie Basso for her editorial assistance in the preparation of this manuscript. We apologize that many articles published during this period could not be cited because of space limitations. This review was supported by NIH grants and the Sbarro Health Organization to AG. GR acknowledges the Ph.D. program ‘Diagnostic, Quantitative and Molecular Pathology’ of the University of Siena, Italy.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antonio Giordano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Russo, G., Zegar, C. & Giordano, A. Advantages and limitations of microarray technology in human cancer. Oncogene 22, 6497–6507 (2003). https://doi.org/10.1038/sj.onc.1206865

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206865

Keywords

This article is cited by

Search

Quick links